Health
Pfizer says BNT162b2 vaccine is effective against new Covid strains – Pharmaceutical Business Review
Pfizer said that BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus.
Pfizer and BioNTech said that their Covid-19 vaccine BNT162b2 has been found to be effective against a key mutation found in two highly transmissible strains of the SARS-CoV-2 virus as per the results from an in vitro study.
The in vitro study, which was held by Pfizer and the University of Texas Medical Branch (UTMB), demonstrated that the antibodies from people subjected to the vaccine could effectively work against the rapidly spreading variants.
Reported initially in the UK and South Africa,…
-
Noosa News18 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business23 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General24 hours agoRush to buy homes before rate cuts send prices soaring
-
Business20 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025